Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Imaging Behav ; 14(5): 2004-2011, 2020 Oct.
Article in English | MEDLINE | ID: mdl-31273672

ABSTRACT

Neuroanatomical correlates of apathy and disinhibition, behavioral abnormalities in behavioral variant Frontotemporal dementia (bvFTD) remain unclear. In this study 45 participants (25 bvFTD patients and 20 controls) provided data on clinical, neuropsychological, behavioral (on Frontal Systems Behavior (FrSBe) Scale), cortical volume (on voxel-based morphometry (VBM)) and tract based spatial fractional anisotropy ((FA) on magnetic resonance imaging (MRI), allowing examination of the neural correlates of apathy and disinhibition. The patients with bvFTD had predominant grey matter loss and corresponding white matter fractional anisotropy reduction in the frontal and temporal lobe compared to the controls. Grey matter loss in frontal, temporal and limbic structures correlated with apathy and degeneration in temporal limbic brain areas correlated with disinhibition. FA changes in inferior fronto-occipital fasciculus and forceps minor correlated with apathy and fibre integrity changes in the superior longitudinal fasciculus correlated with disinhibition. The current study suggests that apathy and disinhibition arises due to changes in the frontal, temporal and limbic brain areas  in bvFTD.


Subject(s)
Apathy , Brain/pathology , Frontotemporal Dementia/pathology , Frontotemporal Dementia/psychology , Brain/diagnostic imaging , Brain/physiopathology , Female , Frontotemporal Dementia/diagnostic imaging , Frontotemporal Dementia/physiopathology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neuropsychological Tests
2.
Brain Imaging Behav ; 12(5): 1221-1228, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29086152

ABSTRACT

Fractal dimension (FD) is a quantitative parameter that can characterizes the complexity of human brain tissue. Extensive grey matter (GM) pathology has been previously identified in Frontotemporal dementia (FTD) and its variants. The aim of the present study was to investigate the GM morphometric abnormalities in the behavioral variant FTD (bvFTD) and primary progressive aphasia (PPA) using FD analysis. Twenty-seven bvFTD, 12 PPA and 20 controls were studied. SPM8 was used to segment the brain into GM tissue. Then the FD values were estimated for the GM skeleton, surface and general structure in patients and controls using our previously published algorithm. We found that patients with bvFTD had significant reduction in FD values of skeleton and general structure when compared to controls. In PPA, more significant decrease in FD was noted in the whole brain and left hemisphere skeleton along with left hemisphere general structure. Only the right hemisphere skeleton had a significant correlation with total score of Frontal Systems Behavior Scale (FrSBe). The results showed that the variants of FTD are associated with disease specific morphometric complexity patterns. These results indicate that FD can be used as a biomarker for the structural changes associated with neurodegenerative diseases.


Subject(s)
Aphasia, Primary Progressive/diagnostic imaging , Brain/diagnostic imaging , Frontotemporal Dementia/diagnostic imaging , Gray Matter/diagnostic imaging , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Algorithms , Female , Fractals , Humans , Imaging, Three-Dimensional , Male , Middle Aged , Nerve Degeneration/diagnostic imaging , Pattern Recognition, Automated/methods
3.
Neurol Asia ; 18(3): 239-248, 2013.
Article in English | MEDLINE | ID: mdl-25431627

ABSTRACT

Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic follow-up of neurodegenerative diseases such as Alzheimer's disease (AD). Structural imaging biomarkers can be used to predict those who are at risk or in preclinical stages of AD. It could possibly be useful even in predicting the conversion of Mild Cognitive Impairment (MCI) an early stage of AD to AD. In addition there has been a lot of progress in molecular imaging in AD. This article presents a review of recent progress in selected imaging biomarkers for early diagnosis, classification, and progression, of AD. A comprehensive integrative strategy initiated early in the cognitive decline is perhaps the most effective method of controlling progression to Alzheimer's disease.

SELECTION OF CITATIONS
SEARCH DETAIL
...